Perioperative therapies for urological cancers

Keyphrases

• Perioperative Therapy 100%
• Urological Cancer 100%
• Adjuvant Therapy 66%
• Combined Modality Therapy 66%
• Neoadjuvant Therapy 66%
• Immune Checkpoint Inhibitors 33%
• Muscle-invasive Bladder Cancer 33%
• Preoperative Chemotherapy 33%
• Prostate Cancer 33%
• Randomized Controlled Trial 33%
• Local Control 33%
• Number of Trials 33%
• Renal Cell Carcinoma 33%
• Bladder Cancer 33%
• Curative Intent 33%
• Cisplatin-based Chemotherapy 33%
• Urothelial Cancer Cells 33%
• Neoadjuvant Cisplatin 33%
• Localized Cancer 33%

Medicine and Dentistry

• Urinary Tract Cancer 100%
• Adjuvant Therapy 66%
• Neoadjuvant Therapy 66%
• Chemotherapy 66%
• Urothelial Cancer 33%
• Immune Checkpoint Inhibitor 33%
• Cisplatin 33%
• Muscle Invasive Bladder Cancer 33%
• Prostate Cancer 33%
• Randomized Controlled Trial 33%
• Clear Cell Renal Cell Carcinoma 33%
• Bladder Cancer 33%
• Multimodality Cancer Therapy 33%